Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
31,076.95 INR | -1.43% |
|
-1.84% | +4.47% |
May. 15 | Abbott India's quarterly profit climbs 28% on strong demand | RE |
May. 15 | Abbott India Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 | CI |
Chart calendar Abbott India Limited
e0de4858e55d95afebfcdeac83451.fIIgRZLJaIsvNgvRkBioqnuHcCSMj8oivc8TAKReHTc.BvhYM9alEtJcBmDo-H7s3i3iREvL_4db-P5hUdUKJQI-6hQEooMQ5kxBRg~5301eb2647b631a2ee1ad002ea742551
Upcoming events on Abbott India Limited
Past events on Abbott India Limited
Past dividends on Abbott India Limited
2024-07-18 | Annual 410 INR |
2023-07-20 | Bonus Payment 145 INR |
2023-07-20 | Annual 180 INR |
2022-08-01 | Bonus Payment 130 INR |
2022-08-01 | Annual 145 INR |
2021-07-18 | Bonus Payment 155 INR |
2021-07-18 | Annual 120 INR |
2020-08-27 | Bonus Payment 143 INR |
2020-08-27 | Annual 107 INR |
2019-08-12 | Bonus Payment 15 INR |
2019-08-12 | Annual 50 INR |
2018-07-09 | Annual 50 INR |
2018-07-09 | Bonus Payment 5 INR |
2017-07-09 | Annual 40 INR |
2016-07-07 | Annual 35 INR |
2015-07-21 | Annual 31 INR |
2014-07-22 | Annual 23 INR |
2013-04-15 | Annual 17 INR |
2012-05-03 | Annual 17 INR |
2011-04-18 | Annual 17 INR |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 49 193 48 885 0.63% | 53 487 54 938 -2.64% | 58 489 58 912 -0.72% | 64 092 64 640 -0.85% | 69 917 | 77 837 |
EBITDA Million INR | Released Forecast Spread | 10 877 10 748 1.2% | 12 056 12 580 -4.16% | 14 531 15 019 -3.25% | 16 946 17 046 -0.59% | 18 957 | 21 394 |
EBIT Million INR | Released Forecast Spread | 10 216 10 175 0.41% | 11 357 12 071 -5.92% | 13 819 14 633 -5.56% | 16 228 17 378 -6.62% | 19 232 | 22 114 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 10 797 10 604 1.82% | 12 738 12 715 0.18% | 16 178 15 752 2.7% | 18 870 18 906 -0.19% | 20 891 | 23 927 |
Net income Million INR | Released Forecast Spread | 7 987 7 909 0.98% | 9 494 9 483 0.11% | 12 012 11 878 1.13% | 14 144 14 114 0.22% | 15 585 | 17 782 |
EPS INR | Released Forecast Spread | 376 371 1.43% | 447 446 0.1% | 565 561 0.72% | 666 664 0.22% | 733 | 837 |
Announcement Date | 17/05/22 | 19/05/23 | 09/05/24 | 15/05/25 |
Quarterly results
Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 13 795 13 718 0.56% | 13 265 13 719 -3.31% | 13 431 13 904 -3.4% | 14 790 14 359 3% | 14 941 15 042 -0.67% | 14 371 14 995 -4.16% | 14 386 14 696 -2.11% | 15 576 15 941 -2.29% | 16 224 | 15 813 | 15 715 |
EBITDA Million INR | Released Forecast Spread | 3 433 3 028 13.38% | 3 165 3 154 0.34% | 2 801 3 384 -17.21% | 3 550 3 183 11.53% | 3 809 3 581 6.35% | 3 877 3 658 5.99% | 3 295 3 640 -9.47% | 3 910 3 994 -2.09% | 4 166 | 4 210 | 4 119 |
EBIT Million INR | Released Forecast Spread | 2 987 2 589 15.37% | 3 697 3 368 9.77% | 3 113 3 654 -14.79% | 3 726 3 518 5.92% | 3 703 | ||||||
Net income Million INR | Released Forecast Spread | 2 655 2 221 19.53% | 2 468 2 476 -0.3% | 2 314 2 537 -8.78% | 2 902 2 463 17.84% | 3 129 2 854 9.66% | 3 110 3 044 2.15% | 2 871 2 859 0.41% | 3 280 3 227 1.65% | 3 376 | 3 381 | 3 473 |
EPS INR | Released Forecast Spread | 125 105 18.66% | 116 110 5.5% | 146 137 6.47% | 135 143 -5.2% | 154 150 2.91% | 150 | |||||
Announcement Date | 14/11/22 | 10/02/23 | 19/05/23 | 09/08/23 | 09/11/23 | 15/01/24 | 09/05/24 | 07/08/24 | - | - | - |
2025-07-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-16 06:45 am | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
2025-07-16 | NOVARTIS AG: Q2 2025 Earnings Release |
2025-07-16 | CAMURUS AB: Q2 2025 Earnings Release |
2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
2025-07-18 05:00 am | ORION OYJ: Q2 2025 Earnings Release |
2025-07-22 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected) |
2025-07-22 | TILRAY BRANDS, INC.: Q4 2025 Earnings Release (Projected) |
2025-07-22 | GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release (Projected) |
Past sector events for Abbott India Limited
2025-06-17 11:45 am | MEDINCELL S.A.: Q4 2025 Earnings Release |
2025-06-10 04:38 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-09 04:48 am | YUNGSHIN GLOBAL HOLDING CORPORATION: May 2025 Sales and Revenue Release |
2025-06-08 08:01 pm | BORA PHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-06 04:47 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-05 04:37 am | TTY BIOPHARM COMPANY LIMITED: May 2025 Sales and Revenue Release |
2025-06-03 04:35 am | ONENESS BIOTECH CO., LTD.: May 2025 Sales and Revenue Release |
2025-05-30 09:46 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2025 Earnings Release |
2025-05-29 07:00 am | ROIVANT SCIENCES LTD.: Q4 2024 Earnings Release |
2025-05-29 04:31 am | ALKEM LABORATORIES LIMITED: Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABBOTINDIA Stock
- Calendar Abbott India Limited
Select your edition
All financial news and data tailored to specific country editions